Skip to main content

Table 8 SF - 36 Physical function scores by group and visit

From: A randomized, double blind, placebo and active comparator controlled pilot study of UP446, a novel dual pathway inhibitor anti-inflammatory agent of botanical origin

    Group P value(Between Groups)
    UP446 250
mg/day
UP446 500
mg/day
Celecoxib
200 mg/day
Placebo  
Visit Baseline Mean 19.53 19.93 21.07 19.40 0.170
   Std
Deviation
1.88 2.15 2.19 2.61  
  30 Days Mean 26.73 27.00 27.00 20.67 0.001
   Std
Deviation
1.49 1.07 2.08 1.72  
  60 Days Mean 27.21 26.77 27.31 21.15 0.001
   Std
Deviation
1.31 1.92 1.44 2.08  
  90 Days Mean 26.36 27.23 25.92 20.23 0.001
   Std
Deviation
1.01 1.54 1.00 1.79